GenomeDx Biosciences

Sep 20, 2018

GenomeDx Achieves Significant Medicare Milestone for Decipher Prostate Biopsy Genomic Classifier

Jul 24, 2018

GenomeDx Announces Medicare Draft Local Coverage Determination (LCD) for Decipher Prostate Biopsy Genomic Classifier

Jun 19, 2018

GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests

May 08, 2018

GenomeDx Biosciences Announces Research Collaboration with Janssen Pharmaceuticals to Evaluate the Decipher® Classifier and Decipher GRID® for Drug Development

Feb 08, 2018

GenomeDx Biosciences' Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at 2018 Genitourinary Cancers Symposium

Sep 21, 2017

GenomeDx's Decipher Cancer Classifier Tests and Genomic Database to be Featured in Multiple Presentations at ASTRO 2017

Sep 14, 2017

GenomeDx to Distribute Pathnostics' Guidance UGx Test for Urinary Tract Infection and Guidance PRx Test for Prostatitis

Jun 29, 2017

GenomeDx Announces New York State CLEP Approval of Decipher Prostate Cancer Tests

Jun 07, 2017

Multiple Studies Further Validate the Importance of Decipher Post-Op in the Treatment of Prostate Cancer